These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4595115)

  • 1. Genetic recombination in Plasmodium berghei.
    Walliker D; Carter R; Morgan S
    Parasitology; 1973 Apr; 66(2):309-20. PubMed ID: 4595115
    [No Abstract]   [Full Text] [Related]  

  • 2. Strain specific immunity to Plasmodium berghei: a new genetic marker.
    Oxbrow AI
    Parasitology; 1973 Aug; 67(1):17-27. PubMed ID: 4579579
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of rodent malaria: transfer of resistance vs mutation.
    Schoenfeld C; Most H; Entner N
    Exp Parasitol; 1974 Oct; 36(2):265-77. PubMed ID: 4606333
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of pyrimethamine resistance on sporogony in a Plasmodium berghei/Anopheles stephensi model.
    Shinondo CJ; Lanners HN; Lowrie RC; Wiser MF
    Exp Parasitol; 1994 Mar; 78(2):194-202. PubMed ID: 8119374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic recombination in malaria parasites.
    Walliker D; Carter R; Morgan S
    Nature; 1971 Aug; 232(5312):561-2. PubMed ID: 4937500
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmodium berghei: routine production of pure gametocytes, extracellular gametes, zygotes, and ookinetes.
    Rodríguez MC; Margos G; Compton H; Ku M; Lanz H; Rodríguez MH; Sinden RE
    Exp Parasitol; 2002 May; 101(1):73-6. PubMed ID: 12243741
    [No Abstract]   [Full Text] [Related]  

  • 7. The chemotherapy of rodent malaria. XVI. Primary resistance to mepacrine in the N67 strain of Plasmodium berghei-type parasite.
    Peters W; Gregory KG
    Ann Trop Med Parasitol; 1973 Jun; 67(2):133-41. PubMed ID: 4578934
    [No Abstract]   [Full Text] [Related]  

  • 8. The chemotherapy of rodent malaria. XVII. Dynamics of drug resistance. 3. Influence of drug combinations on the development of resistance to chloroquine in P. berghei.
    Peters W
    Ann Trop Med Parasitol; 1973 Jun; 67(2):143-54. PubMed ID: 4578935
    [No Abstract]   [Full Text] [Related]  

  • 9. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.
    Hogh B; Gamage-Mendis A; Butcher GA; Thompson R; Begtrup K; Mendis C; Enosse SM; Dgedge M; Barreto J; Eling W; Sinden RE
    Am J Trop Med Hyg; 1998 Feb; 58(2):176-82. PubMed ID: 9502601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of pyrimethamine resistant strain of Plasmodium berghei.
    Agarwal K; Puri SK; Dutta GP
    Indian J Med Res; 1979 Apr; 69():577-82. PubMed ID: 378824
    [No Abstract]   [Full Text] [Related]  

  • 11. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
    Nuralitha S; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AI; Marzuki S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):258-63. PubMed ID: 26503662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antimalarial activity of N-benzyl-oxydihydrotriazines. IV. The development of resistance to BRL 6231 (4,6-diamino-1,2-dihyydro-2-,2-dimethyl-1-(2,4,5-trichloropropyloxy)-1,3,5 triazine hydrochloride) by Plasmodium berghei.
    Knight DJ; Williamson P
    Ann Trop Med Parasitol; 1982 Feb; 76(1):9-14. PubMed ID: 7044325
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood schizontocidal activity of antibiotics against Plasmodium berghei sensitive as well as resistant to chloroquine, pyrimethamine and primaquine.
    Puri SK; Dutta GP
    Indian J Med Res; 1981 Jan; 73 Suppl():29-35. PubMed ID: 7026431
    [No Abstract]   [Full Text] [Related]  

  • 14. The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490).
    Peters W; Portus J; Robinson BL
    Ann Trop Med Parasitol; 1977 Dec; 71(4):419-27. PubMed ID: 339857
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of drug resistance in rodent malaria by the use of drug mixtures.
    Peters W
    Bull World Health Organ; 1974; 51(4):379-83. PubMed ID: 4619060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypothyroidism on parasitemia and survival in rodent malaria.
    Shoemaker JP; McAllister RG; Selby JB; Hoffman RV
    Am J Med Sci; 1974 Nov; 268(5):281-5. PubMed ID: 4617503
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiological and morphological characters in two pyrimethamine-resistant lines of Plasmodium berghei SP11 after cryopreservation.
    Jadin J; Timperman G; De Ruysser F
    Trans R Soc Trop Med Hyg; 1976; 70(3):235-7. PubMed ID: 790672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of pyrimethamine and sulphormethoxine on the pre-erythrocytic and sporogonous cycle of Plasmodium berghei berghei.
    Vincke IH
    Ann Soc Belges Med Trop Parasitol Mycol; 1970; 50(3):339-58. PubMed ID: 5514572
    [No Abstract]   [Full Text] [Related]  

  • 20. The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei.
    Merkli B; Richle R; Peters W
    Ann Trop Med Parasitol; 1980 Feb; 74(1):1-9. PubMed ID: 6990883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.